Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study

Abstract Introduction Ixekizumab, a monoclonal antibody against interleukin-17A, demonstrated effectiveness in the treatment of psoriasis in a Chinese real-world study that was consistent with previous randomized controlled trials. Here, we report further analyses from this study to explore the effe...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Ying Li (Dahkki), Chengzhi Lv (Dahkki), Lin Dang (Dahkki), Bingjiang Lin (Dahkki), Juan Tao (Dahkki), Chunlei Zhang (Dahkki), Xiaoyong Zhou (Dahkki), Han Ma (Dahkki), Yi Lu (Dahkki), Rong Chen (Dahkki), Jinnan Li (Dahkki), Guanshen Dou (Dahkki), Yunsheng Liang (Dahkki), Yanhua Liang (Dahkki), Yuling Shi (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis